POSTS

Post by Barbara W. Unger | April 23, 2019

Week of April 14th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

This week FDA posted 11 warning letters to dietary supplement manufacturers, two to pharma firms and one to a compounding pharmacy.  We cover these last three.

Post by Barbara W. Unger | April 17, 2019

Week of April 7th, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

We cover two warning letters to compounding pharmacies.  The FDA still has not published the warning letter issued to Lupin Pharmaceuticals that the firm disclosed a few weeks ago.

Post by Barbara W. Unger | April 9, 2019

Week of March 31st, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

Enforcement was busy this week. There were six warning letters sent to drug product manufacturers and one to an in vitro diagnostics firm.

Post by Barbara W. Unger | April 4, 2019

Week of March 25, 2019 | FDA Sent These Warning Letters to Pharma/Device Companies

We cover four warning letters from last week, including two to pharmaceutical firms and two to compounding facilities.